Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference11 articles.
1. Winograd EJ, Sollee D, Schauben JL, Kunisaki T, Smotherman C, Gautam S. Pediatric guanfacine exposures reported to the National Poison Data System, 2000–2016. Clin Toxicol. 2020;58:49–55.
2. Bridwell RE, Larson NP, Rosenthal JB, Wray J, Baker Z, Cibrario A, et al. Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema. Am J Emerg Med. 2021;39:256.e5-256.e8.
3. Martinez-Raga J, Knecht C, Szerman N, Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs. 2013;27:15–30.
4. Martin P, Satin L, Kahn RS, Robinson A, Corcoran M, Purkayastha J, et al. A thorough QT study of guanfacine. Int J Clin Pharmacol Ther. 2014;53:301–16.
5. Schulz M, Schmoldt A, Andresen-Streichert H, Iwersen-Bergmann S. Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care. 2020;24:195.